Pharming Group (OTCMKTS:PHGUF) Short Interest Down 30.8% in March

Pharming Group (OTCMKTS:PHGUF) saw a large decrease in short interest in March. As of March 31st, there was short interest totalling 3,342,300 shares, a decrease of 30.8% from the March 15th total of 4,828,600 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ? days. Currently, 0.5% of the company’s stock are sold short.

Pharming Group Price Performance

Shares of OTCMKTS PHGUF remained flat at $0.90 during mid-day trading on Friday. The firm has a 50-day simple moving average of $0.89 and a 200 day simple moving average of $0.86. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.76 and a current ratio of 3.53. Pharming Group has a 12-month low of $0.75 and a 12-month high of $1.07. The firm has a market cap of $603.97 million, a P/E ratio of -45.00 and a beta of 0.91.

Pharming Group Company Profile

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.